ERDEVE, O. Et Al. 2012. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION , vol.97, no.4 .

ERDEVE, O., YURTTUTAN, S., ALTUG, N., Ozdemir, R., GOKMEN, T., DILMEN, U., ... OGUZ, S. S.(2012). Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION , vol.97, no.4.

ERDEVE, Omer Et Al. "Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants," ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION , vol.97, no.4, 2012

ERDEVE, Omer Et Al. "Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants." ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION , vol.97, no.4, 2012

ERDEVE, O. Et Al. (2012) . "Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants." ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION , vol.97, no.4.

@article{article, author={Omer ERDEVE Et Al. }, title={Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants}, journal={ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION}, year=2012}